The ICMR analysis found that the BPaL regimen is "both more effective and cost-saving" compared to the current standard of ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

Nagpur: Short-duration, all-oral treatment regimens used in India for drug-resistant tuberculosis (TB) are not only ...

UB researchers have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden ...

Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.

AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response ...

An ICMR study has found that the six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant ...

In the wake of a recent outbreak of tuberculosis (TB) and latent TB cases at a local San Francisco high school, IGHS's Priya ...

CureTB referrals showed higher TB treatment completion when patients were linked to care quickly after relocation.

Shorter, six month and alloral treatment regimens for multidrugresistant and rifampicinresistant tuberculosis (MDR/RRTB) are costeffective and deliver better health outcomes than longer regimens.

This economic evaluation of the shorter regimen published in the Indian Journal of Medical Research also assessed the ...